No racial difference in allele frequencies of FCGR3A gene F158V polymorphisms in diffuse large B-cell lymphoma

被引：2
|
作者：
Hirakawa, Tsuneaki
Yamaguchi, Hiroki [1 ]
Mitamura, Yoshio [2 ]
Kosaka, Fumiko
Dan, Kazuo
Inokuchi, Koiti
机构：
[1] Nippon Med Sch, Dept Internal Med, Div Hematol, Bunkyo Ku, Tokyo 1138603, Japan
[2] Sekino Clin Pharmacol Clin, Dept Internal Med, Tokyo, Japan
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2011年 / 86卷 / 02期
关键词：
FC-GAMMA-RIIIA; NON-HODGKINS-LYMPHOMA; V/F POLYMORPHISM; PREDICT RESPONSE; RITUXIMAB; CHOP;
D O I：
10.1111/j.1600-0609.2010.01554.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：180 / 181
页数：2
相关论文
共 50 条
  • [41] Association between LAPTM4B gene polymorphism and susceptibility to and prognosis of diffuse large B-cell lymphoma
    Ding, Huirong
    Cheng, Xiaojing
    Ding, Ning
    Tian, Zhihua
    Zhu, Jun
    Zhou, Chunlian
    Shen, Jing
    Song, Yuqin
    ONCOLOGY LETTERS, 2018, 15 (01) : 264 - 270
  • [42] Quercetin Potentiates the Antitumor Activity of Rituximab in Diffuse Large B-Cell Lymphoma by Inhibiting STAT3 Pathway
    Li, Xin
    Wang, Xinhua
    Zhang, Mingzhi
    Li, Aimin
    Sun, Zhenchang
    Yu, Qi
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2014, 70 (02) : 1357 - 1362
  • [43] Combination of YM155, a survivin suppressant with a STAT3 inhibitor: A new strategy to treat diffuse large B-cell lymphoma
    Kaneko, Naoki
    Kita, Aya
    Yamanaka, Kentaro
    Mori, Masamichi
    LEUKEMIA RESEARCH, 2013, 37 (09) : 1156 - 1161
  • [44] Progressive diffuse large B-cell lymphoma with TP53 gene mutation treated with chidamide-based chemotherapy
    Li, Qing
    Huang, Jingcao
    Ou, Yang
    Li, Yan
    Wu, Yu
    IMMUNOTHERAPY, 2019, 11 (04) : 265 - 272
  • [45] [18F]Fluorothymidine PET imaging in the diagnosis of leptomeningeal involvement with diffuse large B-cell lymphoma
    Holter, Jennifer L.
    Thorp, Kristin
    Smith, M. Leann
    Kedzierska, Katarzyna
    Fung, Kar-Ming A.
    Chacko, George
    Swisher, Karen
    Epstein, Robert
    Gumerlock, Mary K.
    CANCER IMAGING, 2011, 11 (01): : 140 - 143
  • [46] CD38 and Interleukin 6 Gene Polymorphism in Egyptians with Diffuse Large B-Cell Lymphoma (DLBCL)
    Talaat, Roba M.
    Abdel-Aziz, Amal M.
    El-Maadawy, Eman A.
    Abdel-Bary, Naser
    IMMUNOLOGICAL INVESTIGATIONS, 2015, 44 (03) : 265 - 278
  • [47] Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults
    Guadamuz, Jenny S.
    Ozenberger, Katharine
    Qato, Dima M.
    Ko, Naomi Y.
    Saffore, Christopher D.
    Adimadhyam, Sruthi
    Cha, Ashley S.
    Moran, Kellyn M.
    Sweiss, Karen
    Patel, Pritesh R.
    Chiu, Brian C. -H.
    Calip, Gregory S.
    MEDICINE, 2019, 98 (46) : e17960
  • [48] Hypermethylation of p15 Gene in Diffuse - Large B-Cell Lymphoma: Association with Less Aggressiveness of the Disease
    Krajnovic, Milena
    Jovanovic, Maja Perunicic
    Mihaljevic, Biljana
    Andelic, Bosko
    Tarabar, Olivera
    Knezevic-Usaj, Slavica
    Krtolica, Koviljka
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2014, 7 (05): : 384 - 390
  • [49] Prognostic significance of interim 18F-FDG PET/CT SUV reduction associated with Ki67 in patients with diffuse large B-cell lymphoma
    Sun Yi-Wen
    Zhao Jin-Hua
    Qiao Wen-Li
    Xing Yan
    Chen Xiang
    Song Jian-Hua
    NUCLEAR SCIENCE AND TECHNIQUES, 2014, 25 (02)
  • [50] Rituximab regulates signaling pathways and alters gene expression associated with cell death and survival in diffuse large B-cell lymphoma
    Koivula, Satu
    Valo, Erkka
    Raunio, Anna
    Hautaniemi, Sampsa
    Leppa, Sirpa
    ONCOLOGY REPORTS, 2011, 25 (04) : 1183 - 1190
12345